{
  "docId": "019dd923-622c-750b-8b9b-a88f4b1599da",
  "docSlug": "2a2da42210b1",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": "Pershing Square Holdings",
  "documentKindSlug": "press-release",
  "documentKindLabel": "Press release",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2016-03-21 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 1,
  "pageCount": 1,
  "prevPage": null,
  "nextPage": null,
  "slideType": "press-release",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": "https://imgproxy.kitesheet.com/XkETKPN-TvUU2wF3XyhBd_8iyfC0J8TWixN9HYX367U/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTJkYTQyMjEwYjEvcDAwMS5qcGc",
  "slideHref": "/slides/019dd923-622c-750b-8b9b-a88f4b1599da/1",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-a88f4b1599da",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-a88f4b1599da.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-a88f4b1599da#slide-1",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.78,
        "x": 0.11,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "Amsterdam, 21 Mar. 2016 //- Pershing Square Holdings, Ltd. today released an email to investors. The text of the email is set forth below:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "442f04a0-f64b-414a-95c7-81413b31ca05",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.11,
        "y": 0.21
      },
      "kind": "paragraph",
      "text": "Dear Pershing Square Investor, Today Valeant Pharmaceuticals International, Inc. issued a press release announcing developments at the company. Please find below a link to the press release on the Valeant web site.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b7543e2-b8f8-4795-8fe5-ed3c71a92d7f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.78,
        "x": 0.11,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "Pershing Square Holdings, Ltd. (PSH:NA) is an investment holding company structured as a closed end fund that makes concentrated investments principally in North American companies.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "810d704a-f8ef-40a8-889e-3ae80167839f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.11,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "http://ir.valeant.com/news-releases/2016/03-21-2016-125936508",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eafeee1e-86c4-4f9b-a833-2d0f331a3624",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.2,
        "x": 0.11,
        "y": 0.31
      },
      "kind": "paragraph",
      "text": "Kind regards, Pershing Square IR ir@persq.com",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ebdc8c24-cf4c-4cf8-bd3e-bfa1f238db05",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.09
      },
      "kind": "title",
      "text": "Pershing Square Holdings, Ltd. Communicates with Shareholders Regarding Developments at Valeant Pharmaceuticals International, Inc.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9ed6b8f-8808-42bc-b570-c4bec216c628",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.11,
        "y": 0.43
      },
      "kind": "title",
      "text": "About Pershing Square Holdings, Ltd.",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "916f11fd-2190-4d60-b719-bd4f311d3de1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 1,
      "from": 1,
      "beatId": "376645f4-9b64-4592-a1d1-5b0a48ed4eea",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Attention",
      "beatSlug": "aida-attention",
      "evidence": "The press release aims to grab the attention of shareholders regarding developments at Valeant Pharmaceuticals International, Inc.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Hook",
      "parentBeatSlug": "hook"
    }
  ],
  "loops": [],
  "imagePathAlt": "https://imgproxy.kitesheet.com/hY2ot2XmnVingQA293aFySRoBXiY-1UAghBvU2ImeoM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTJkYTQyMjEwYjEvcDAwMS5wbmc",
  "thumbSrc": "https://imgproxy.kitesheet.com/S2qiVGxxkPthQD6Du653fgO4M4NbiI4qTDV8CObmMqE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTJkYTQyMjEwYjEvcDAwMS5qcGc",
  "thumbSrcAlt": "https://imgproxy.kitesheet.com/yr1IzIAQBtVdpHLHLcjVqqItIHDpKHiULIhJ6PBEF1E/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yYTJkYTQyMjEwYjEvcDAwMS5wbmc"
}